1st Circ. Hands Hearing Loss Biotech Win In Stock Drop Suit
A panel of the First Circuit declined to revive an investor class action alleging that a hearing loss treatment company and some of its executives concealed disappointing clinical trial results, saying...To view the full article, register now.
Already a subscriber? Click here to view full article